Precipio, Inc., a leading biotechnology firm headquartered in the United States, has established itself as a key player in the precision medicine industry since its founding in 2011. With a focus on innovative diagnostic solutions, Precipio is dedicated to enhancing patient care through advanced molecular testing and personalised treatment strategies. The company operates primarily in the oncology sector, offering unique products such as its proprietary HemeScreen and HemeTrace assays, which provide critical insights for blood cancer diagnosis and management. Precipio's commitment to accuracy and efficiency has positioned it as a trusted partner for healthcare providers, contributing to significant advancements in patient outcomes. With a strong market presence and a reputation for excellence, Precipio continues to drive innovation in the field of diagnostics.
How does Precipio, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Precipio, Inc.'s score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Precipio, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Precipio may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives. As such, the company appears to be in the early stages of addressing climate-related impacts, with no inherited emissions data from a parent or related organization.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Precipio, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
